SKIP000766 |
SKIP ID |
SKIP000766 |
Organism(En) |
- |
Organism(Ja) |
- |
Cell Type(En) |
- |
Cell Type(Ja) |
- |
Cell Tissue(En) |
- |
Cell Tissue(Ja) |
- |
Cell Origin |
Diseased |
Cell Name 1(En) |
ARVC-iPSC |
Cell Name 1(Ja) |
ARVC-iPSC |
Cell Name 2(En) |
- |
Cell Name 2(Ja) |
- |
Disease Name 1(Ja) |
不整脈源性右室心筋症 |
ICD Code 1 |
I428 |
Disease Name 1(En) |
arrhythmogenic right ventricular cardiomyopathy |
OMIM1 |
609040 |
Disease Name 2(Ja) |
- |
ICD Code 2 |
- |
Disease Name 2(En) |
- |
OMIM 2 |
- |
Disease Name 3(Ja) |
- |
ICD Code 3 |
- |
Disease Name 3(En) |
- |
OMIM 3 |
- |
Age |
30 |
Age Range |
30-39 |
Sex |
Male |
Race(En) |
Chinese |
Race(Ja) |
- |
Genetic Diagnosis |
Yes |
Not Detected |
No |
Description(En) |
Disease specific iPS cell from ARVC. |
Description(Ja) |
不整脈源性右室心筋症患者由来iPS細胞 |
Cell Morphology |
human ES-like |
Grade |
Research Grade |
Vector |
Retrovirus |
Transgene |
SOX2, OCT3/4, KLF4, and C-MYC |
Adhesiveness |
- |
Feeder |
Yes |
Feeder Cell |
- |
Medium |
80% Knockout DMEM, 20% serum replacement, 1% non-essential amino acid, 1 mM L-glutamine, 0.1 mM β-mercaptoebthanol and 10 ng/ml basic fibroblast growth factor. |
Genome Editing |
- |
CO2 |
5% |
Mycoplasma |
Unknown |
Detection of Contaminants Mycoplasma |
- |
Pluripotent Markers |
Yes |
Pluripotent Markers Assay |
Immunostaining |
in vitro Differentiation |
Yes |
in vitro Differentiation Assay |
cardiomyocyte differentiation |
in vivo Differentiation |
Yes |
in vivo Differentiation Assay |
Teratoma formation |
Other 1 Assay |
- |
Other 1 Assay Method |
- |
Other 2 Assay |
Yes |
Other 2 Assay Method |
cardiac electrophysiology |
Other 3 Assay |
- |
Other 3 Assay Method |
- |
Karyotype |
No |
Karyotype Assay |
- |
Remaining Vector Detection |
Yes |
Remaining Vector Detection Assay |
- |
STR |
No |
HLA |
No |
Stem Cell Transcriptome analysis |
No |
Stem Cell Transcriptome analysis Assay |
- |
Author Name(En) |
Dongrui Ma |
Author Name(Ja) |
Dongrui Ma |
Author Organization(En) |
Research and Development Unit (RDU), National Heart Centre |
Author Organization(Ja) |
Research and Development Unit (RDU), National Heart Centre |
Author Contact Email |
reginald[dot]liew[dot]k[dot]c[at]nhcs[dot]com[dot]sg |
PI Organization(En) |
Research and Development Unit (RDU), National Heart Centre |
PI Organization(Ja) |
Research and Development Unit (RDU), National Heart Centre |
PI Name(En) |
Reginald Liew |
PI Name(Ja) |
Reginald Liew |
PI Contact Email |
reginald[dot]liew[dot]k[dot]c[at]nhcs[dot]com[dot]sg |
Availability |
Information Only |
Provider Organization(En) |
- |
Provider Organization(Ja) |
- |
Provider Email |
- |
Provider URL |
- |
Ethical Statement(En) |
- |
Ethical Statement(Ja) |
- |
Terms of Use(En) |
- |
Terms of Use(Ja) |
- |
PubMed ID |
22798562 |
DOI |
10.1093/eurheartj/ehs226 |
Title |
Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy. |
Authors |
Ma D, Wei H, Lu J, Ho S, Zhang G, Sun X, Oh Y, Tan SH, Ng ML, Shim W, Wong P, Liew R |
Journal |
Eur Heart J |
Year |
2012 |
Volume |
34 |
Issue |
15 |
Pages |
1122-33 |
URL |
http://www.ncbi.nlm.nih.gov/pubmed/22798562 |
Free input |
- |
Note |
- |